These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24645187)

  • 21. [Anticoagulants and dual antiplatelet therapy combined, a challenge to our intelligence].
    Morais J
    Rev Port Cardiol; 2012 Apr; 31 Suppl 1():38-44. PubMed ID: 22541034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New concepts and approaches to stroke prevention in the new European Society of Cardiology guidelines for the management of atrial fibrillation.
    Kuzniatsova N; Lip GY
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1643-7. PubMed ID: 21108546
    [No Abstract]   [Full Text] [Related]  

  • 23. The Year in Cardiology 2012: acute coronary syndromes.
    West NE
    Eur Heart J; 2013 Feb; 34(6):422-6. PubMed ID: 23284094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation: the clinical dilemma of triple therapy.
    Fitchett D; Verma A; Eikelboom J; Madan M; Cohen E; Bell A; Dorian P
    Curr Opin Cardiol; 2014 Jan; 29(1):1-9. PubMed ID: 24284976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of antiplatelet agents and anticoagulants in post-myocardial infarction.
    Fiore LD; Deykin D
    Cardiol Clin; 1994 Aug; 12(3):451-76. PubMed ID: 7805079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comments on the ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.
    ; Fernández-Ortiz A; Pan M; Alfonso F; Arós F; Barrabés JA; Bodí V; Cequiera A; García-Moll X; Jiménez-Candil J; López-Palop R; Peña C; Worner F; ; Alonso Gómez AM; Anguita M; Cequier A; Comín J; Fernández-Ortiz A; Pan M; Worner F; Alonso J; Bardají A; Barón-Esquivias G; Bover R; Angel-Ferrer J; Goicolea J; Gómez-Doblas JJ; Iñiguez A; Mainar V; Marín F; Pedreira M; Roldán I; Sabaté M; Sánchez PL; Sanchis J
    Rev Esp Cardiol (Engl Ed); 2012 Feb; 65(2):125-30. PubMed ID: 22265200
    [No Abstract]   [Full Text] [Related]  

  • 28. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
    Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
    Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conclusion.
    Atar D; Serebruany VL
    Adv Cardiol; 2012; 47():165. PubMed ID: 22906911
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
    MMW Fortschr Med; 2008 Oct; 150(42):52-3. PubMed ID: 18983063
    [No Abstract]   [Full Text] [Related]  

  • 31. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Stenestrand U; Lindbäck J; Wallentin L;
    Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines.
    Antman EM
    Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin + clopidogrel therapy: how does your care compare to the evidence?
    Simmons BB; Salzman BE
    J Fam Pract; 2008 Jan; 57(1):26-32. PubMed ID: 18171566
    [No Abstract]   [Full Text] [Related]  

  • 34. [Old patient with atrial fibrillation: do you too hesitate to use anticoagulants?].
    MMW Fortschr Med; 2006 Sep; 148(38):14. PubMed ID: 17036954
    [No Abstract]   [Full Text] [Related]  

  • 35. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
    Mooe T
    Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
    [No Abstract]   [Full Text] [Related]  

  • 37. Anticoagulants in coronary artery disease.
    Lee LV
    Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy.
    Fosbol EL; Wang TY; Li S; Piccini J; Lopes RD; Mills RM; Klaskala W; Thomas L; Roe MT; Peterson ED
    Am Heart J; 2013 Nov; 166(5):864-70. PubMed ID: 24176442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel antiplatelet and anticoagulant agents in the cardiac care unit.
    Garg VP; Halperin JL
    Cardiol Clin; 2013 Nov; 31(4):533-44, viii. PubMed ID: 24188219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role?
    Mukherjee D; Roffi M
    J Interv Cardiol; 2008 Apr; 21(2):118-21. PubMed ID: 18384343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.